サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1763232

腎臓・泌尿器機器の世界市場

Nephrology And Urology Devices

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.69円
腎臓・泌尿器機器の世界市場
出版日: 2025年07月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

腎臓・泌尿器機器の世界市場は2030年までに393億米ドルに達する見込み

2024年に279億米ドルと推定される腎臓・泌尿器機器の世界市場は、2024～2030年の分析期間においてCAGR 5.9%で成長し、2030年には393億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである透析装置は、CAGR 6.2％を記録し、分析期間終了時には289億米ドルに達すると予想されます。内視鏡機器セグメントの成長率は、分析期間でCAGR 5.4%と推定されます。

米国市場は73億米ドル、中国はCAGR8.9％で成長予測

米国の腎臓・泌尿器機器市場は、2024年に73億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR 8.9%を牽引し、2030年までに市場規模91億米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.9%と5.4%と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界の腎臓・泌尿器機器市場- 主要動向と促進要因のまとめ

腎臓・泌尿器機器とは何か、なぜ現代ヘルスケアにおいて重要なのか？

腎臓・泌尿器機器には、腎臓、尿路、膀胱、および関連臓器に影響を及ぼす症状の診断、治療、管理を目的とした幅広い医療機器が含まれます。これらの機器は、慢性腎臓病、尿失禁、腎結石、前立腺肥大症、泌尿器系のがんなど、さまざまな疾患に対処するために使用されます。例えば、透析器、カテーテル、尿管鏡、砕石器、尿道ステント、腎瘻造設器などがあります。これらの機器は、患者の予後を改善し、低侵襲の治療オプションを提供し、急性および慢性疾患の長期管理をサポートする上で重要な役割を果たしています。

腎臓・泌尿器機器の重要性は、効果的な疾患管理、より迅速な回復、より低侵襲な処置を可能にすることで、患者のQOLを向上させる能力にあります。慢性腎臓病や末期腎臓病の患者にとって、透析装置は腎機能の維持と延命のために不可欠です。泌尿器科疾患の場合、ステント、カテーテル、レーザーシステムなどの機器により、閉塞、感染症、その他の合併症を効果的に管理することができます。人口の高齢化、ライフスタイル要因、糖尿病や高血圧などの併存疾患により、腎臓関連疾患や泌尿器系疾患の有病率が世界的に上昇し続けているため、これらの機器は現代医療の提供に不可欠な要素となっています。

技術の進歩は腎臓・泌尿器機器市場をどのように形成しているか？

技術の進歩は、腎臓・泌尿器機器に関連する精度、効率、患者の転帰を大幅に向上させ、ヘルスケア分野全体のイノベーションを促進しています。主な開発のひとつに低侵襲技術の台頭があり、腎臓内科と泌尿器科の外科手術や治療介入を一変させました。軟性尿管鏡、レーザー結石破砕装置、ロボット支援システムなどの治療により、回復時間の短縮、合併症の最小化、ヘルスケアコストの削減を実現しながら、腎結石、腫瘍、その他の閉塞を正確に治療できるようになりました。例えば、ロボット手術は、より優れた可視化、より優れたコントロール、より小さな切開を可能にし、前立腺摘除術や腎部分切除術のような手技において特に効果的です。

透析技術の進歩は、慢性腎臓病や末期腎臓病の治療を改善しました。最新の透析装置は、濾過システムの改良、モニタリング機能の向上、より使いやすいインターフェースを備えており、治療をより安全で効率的なものにし、患者さんの負担を軽減しています。携帯型透析装置や装着型透析装置の開発により、在宅医療の選択肢はさらに広がり、患者さんはより機動的かつ柔軟に病状を管理できるようになりました。さらに、現在進行中の埋め込み型人工腎臓の研究は、腎不全患者にとってより永続的で制約の少ない解決策を提供し、腎代替療法に革命をもたらす可能性を秘めています。

デジタルヘルスツールや遠隔モニタリングソリューションの開発も、腎臓・泌尿器科疾患の管理を強化しています。遠隔医療、ウェアラブルセンサー、モバイルヘルスアプリは現在、体液量、血圧、尿量などの患者の健康指標の追跡に使用され、治療計画を最適化するためのリアルタイムのデータをヘルスケア専門家に提供しています。例えば、透析や尿閉の治療を受けている患者の継続的なモニタリングは、合併症の早期発見に役立ち、タイムリーな介入を可能にし、病院の再入院を減らすことができます。このような技術革新は、腎臓・泌尿器機器の機能を拡張するだけでなく、現代のヘルスケアにおける個別化、データ主導、患者中心のケアという幅広い動向にも合致しています。

様々な患者グループにおける腎臓・泌尿器機器の新たなアプリケーションとは？

腎臓・泌尿器機器は、腎臓や泌尿器疾患の有病率の増加や、より効果的で侵襲の少ない治療オプションの必要性により、様々な患者グループへの応用が拡大しています。例えば、腎結石の治療では、尿管鏡、砕石器、ステントが結石の除去や破砕を容易にするために広く使用されています。これらの器具は成人から小児に至るまで一般的に使用されており、急性期の管理や長期的な再発予防に効果的なソリューションを提供しています。非侵襲的に結石を破砕する体外衝撃波結石破砕術（ESWL）は、合併症が少なく回復が早いため、好ましい治療法となっています。

慢性腎臓病や末期腎臓病の患者にとって、透析装置は腎機能を維持するために不可欠です。血液透析と腹膜透析では、患者のニーズが異なり、血液透析の方が臨床現場で一般的であり、腹膜透析の方が在宅医療に柔軟に対応できます。最近の進歩は、患者の快適性の向上、治療期間の短縮、効率の向上に重点を置いています。例えば、ポータブル透析装置は、患者が自宅や旅行先で透析を受けることを可能にし、より自律的でQOLの高い治療を提供します。

前立腺肥大症（BPH）の治療では、前立腺ステント、経尿道的前立腺切除術（TURP）装置、レーザーシステムなどの機器が、特に高齢の男性患者の間で標準的な治療選択肢となっています。これらの機器は、尿閉塞の効果的な緩和と尿流の改善をもたらし、入院期間の短縮と合併症リスクの低減を伴う低侵襲的な解決策を提供します。さらに、カテーテル、スリング、仙骨神経調節インプラントなどの尿失禁器具は、さまざまなタイプの失禁に的を絞ったソリューションを提供し、幅広い年齢層の男女患者のニーズに対応しています。

がん治療では、生検、腫瘍切除、外科的介入に腎臓・泌尿器機器が使用されます。腹腔鏡下腎摘出術、膀胱鏡、レーザーアブレーションシステムなどの治療器具により、健康な組織を温存したまま、がん組織を正確に切除・治療することができます。高度な画像技術をこれらの機器と併用することで、腎細胞がんや膀胱がんなどの早期発見、診断、標的治療が向上しています。これらの患者グループにおける腎臓・泌尿器機器の用途の拡大は、患者の予後を改善し、QOLを向上させ、腎臓・泌尿器疾患の包括的治療をサポートする上で、腎臓・泌尿器機器が重要な役割を担っていることを浮き彫りにしています。

腎臓・泌尿器機器市場の成長の原動力は？

腎臓・泌尿器機器市場の成長は、腎臓・泌尿器疾患の有病率の増加、低侵襲治療に対する需要の高まり、医療技術の進歩など、いくつかの要因によってもたらされます。主な成長要因の1つは、人口の高齢化、ライフスタイルの変化、糖尿病や高血圧の罹患率の上昇などに起因する慢性腎臓病や末期腎臓病の世界の増加です。長期管理や腎代替療法を必要とする患者の増加に伴い、透析装置、カテーテル、その他の関連機器に対する需要が増加し、市場の拡大を支えています。

低侵襲手術手技への嗜好の高まりも、先進的な泌尿器科機器の需要を促進しています。患者やヘルスケアプロバイダーは、回復が早く、痛みが少なく、合併症が少ない治療を選ぶようになってきています。腎結石に対するレーザー結石破砕術や前立腺腫瘍・腎腫瘍に対するロボット支援手術などの低侵襲技術が一般的な選択肢となり、尿管鏡、レーザー、ロボットシステムの需要を牽引しています。このような低侵襲治療へのシフトは、腎臓・泌尿器疾患の治療においてより優れた精度、安全性、有効性を提供する革新的な機器の採用を支えています。

デジタルヘルスツールやポータブル機器などの医療技術の進歩は、治療へのアクセスや患者の転帰を改善することで市場の成長に寄与しています。ウェアラブルセンサー、遠隔監視装置、モバイルヘルスアプリケーションなどの革新は、慢性疾患を持つ患者の継続的なモニタリングを可能にし、より良い疾患管理とタイムリーな介入をサポートします。例えば、在宅透析装置により、より多くの患者が従来の臨床環境以外で治療を受けられるようになり、利便性が向上し、ヘルスケアコストが削減されます。このような進歩は、個別化された患者中心のケアや統合されたデジタル・ソリューションを目指す、より広範なヘルスケアの動向と一致しています。

政府の取り組みやヘルスケア・インフラの整備も、腎臓・泌尿器機器市場の牽引役として重要な役割を果たしています。医療費の増加、保険適用範囲の改善、腎臓・泌尿器科の健康に対する国民の意識向上キャンペーンが、先進地域と発展途上地域の両方で医療機器の採用を後押ししています。新たな機器の承認や償還政策に対する規制当局の支援は、先進的な治療オプションへのアクセスをさらに促進し、世界市場における腎臓・泌尿器機器の幅広い利用可能性を保証しています。

腎臓・泌尿器機器市場は、医療機器、遠隔医療、低侵襲技術における継続的な技術革新により、継続的な成長が見込まれています。これらの動向は、効果的な疾病管理、患者の転帰改善、高度な治療オプションに対する需要の高まりと相まって、腎臓・泌尿器機器を多様な患者集団における現代のヘルスケア戦略に不可欠な要素にしています。

セグメント

タイプ別（透析装置,内視鏡装置,前立腺肥大症治療装置,尿失禁および骨盤臓器脱治療装置,尿路結石治療装置,その他）

調査対象企業の例

  • Asahi Kasei Corp
  • B. Braun Group
  • Boston Scientific Corporation
  • Siemens Healthineers
  • Cardinal Health Inc.
  • Cook Group Incorporated
  • Dornier Medtech
  • Medtronic plc
  • Olympus Europa SE & Co. KG
  • Teleflex Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP16622

Global Nephrology And Urology Devices Market to Reach US$39.3 Billion by 2030

The global market for Nephrology And Urology Devices estimated at US$27.9 Billion in the year 2024, is expected to reach US$39.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Dialysis Devices, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$28.9 Billion by the end of the analysis period. Growth in the Endoscopy devices segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.3 Billion While China is Forecast to Grow at 8.9% CAGR

The Nephrology And Urology Devices market in the U.S. is estimated at US$7.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.1 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Nephrology and Urology Devices Market - Key Trends & Drivers Summarized

What Are Nephrology and Urology Devices, and Why Are They So Crucial in Modern Healthcare?

Nephrology and urology devices encompass a broad range of medical equipment designed to diagnose, treat, and manage conditions affecting the kidneys, urinary tract, bladder, and associated organs. These devices are used to address a variety of disorders, including chronic kidney disease, urinary incontinence, kidney stones, benign prostatic hyperplasia, and cancers of the urinary system. Examples include dialysis machines, catheters, ureteroscopes, lithotripters, urinary stents, and nephrostomy devices, among others. These devices play a crucial role in improving patient outcomes, providing minimally invasive treatment options, and supporting long-term management of both acute and chronic conditions.

The importance of nephrology and urology devices lies in their ability to enhance the quality of life for patients by enabling effective disease management, faster recovery, and less invasive procedures. For patients with chronic kidney disease or end-stage renal disease, dialysis machines are essential for maintaining kidney function and prolonging life. In cases of urological disorders, devices like stents, catheters, and laser systems allow for effective management of obstructions, infections, and other complications. As the prevalence of kidney-related and urological conditions continues to rise globally-due to aging populations, lifestyle factors, and comorbidities like diabetes and hypertension-these devices have become vital components of modern healthcare delivery.

How Are Technological Advancements Shaping the Nephrology and Urology Devices Market?

Technological advancements have significantly enhanced the precision, efficiency, and patient outcomes associated with nephrology and urology devices, driving innovation across the healthcare sector. One of the major developments is the rise of minimally invasive technologies, which have transformed surgical and therapeutic interventions in both nephrology and urology. Devices such as flexible ureteroscopes, laser lithotripters, and robotic-assisted systems allow for precise treatment of kidney stones, tumors, and other obstructions with reduced recovery times, minimal complications, and lower healthcare costs. Robotic surgery, for instance, enables enhanced visualization, better control, and smaller incisions, making it particularly effective in procedures like prostatectomy and partial nephrectomy.

Advancements in dialysis technology have improved the treatment of chronic kidney disease and end-stage renal disease. Modern dialysis machines feature improved filtration systems, better monitoring capabilities, and more user-friendly interfaces, making treatments safer, more efficient, and less burdensome for patients. The development of portable and wearable dialysis devices has further expanded the options for home-based care, allowing patients greater mobility and flexibility in managing their condition. Additionally, ongoing research into implantable artificial kidneys holds the potential to revolutionize renal replacement therapy, offering more permanent and less restrictive solutions for kidney failure patients.

The development of digital health tools and remote monitoring solutions has also enhanced the management of nephrology and urology conditions. Telemedicine, wearable sensors, and mobile health apps are now used to track patient health metrics, such as fluid levels, blood pressure, and urine output, providing healthcare professionals with real-time data to optimize treatment plans. For example, continuous monitoring of patients undergoing dialysis or treatment for urinary retention can help detect complications early, enabling timely interventions and reducing hospital readmissions. These technological innovations not only expand the capabilities of nephrology and urology devices but also align with broader trends toward personalized, data-driven, and patient-centric care in modern healthcare.

What Are the Emerging Applications of Nephrology and Urology Devices Across Different Patient Groups?

Nephrology and urology devices are finding expanding applications across diverse patient groups, driven by increasing prevalence of kidney and urological disorders and the need for more effective, less invasive treatment options. In the treatment of kidney stones, for example, ureteroscopes, lithotripters, and stents are widely used to facilitate stone removal or fragmentation. These devices are commonly employed across adult and pediatric populations, offering effective solutions for acute management and long-term prevention of recurrence. The use of extracorporeal shock wave lithotripsy (ESWL), which breaks down stones non-invasively, has become a preferred treatment method due to its minimal complications and faster recovery times.

For patients with chronic kidney disease or end-stage renal disease, dialysis machines are essential for maintaining kidney function. Hemodialysis and peritoneal dialysis devices serve different patient needs, with hemodialysis being more common in clinical settings and peritoneal dialysis offering greater flexibility for home-based care. Recent advancements have focused on improving patient comfort, reducing treatment duration, and enhancing efficiency. Portable dialysis machines, for instance, allow patients to receive dialysis at home or while traveling, providing more autonomy and a better quality of life.

In the management of benign prostatic hyperplasia (BPH), devices like prostatic stents, transurethral resection of the prostate (TURP) equipment, and laser systems have become standard treatment options, particularly among older male patients. These devices provide effective relief from urinary obstruction and improve urine flow, offering minimally invasive solutions with shorter hospital stays and reduced risks of complications. In addition, urinary incontinence devices, such as catheters, slings, and sacral neuromodulation implants, offer targeted solutions for different types of incontinence, addressing the needs of both male and female patients across a wide age range.

In cancer treatment, nephrology and urology devices are used for biopsy, tumor ablation, and surgical interventions. Devices like laparoscopic nephrectomy tools, cystoscopes, and laser ablation systems allow for precise removal or treatment of cancerous tissues while preserving healthy structures. The use of advanced imaging technologies in conjunction with these devices has improved early detection, diagnosis, and targeted treatment of cancers like renal cell carcinoma and bladder cancer. The expanding applications of nephrology and urology devices across these patient groups highlight their critical role in enhancing patient outcomes, improving quality of life, and supporting comprehensive care for kidney and urological disorders.

What Drives Growth in the Nephrology and Urology Devices Market?

The growth in the nephrology and urology devices market is driven by several factors, including increasing prevalence of kidney and urological disorders, rising demand for minimally invasive treatments, and advancements in medical technology. One of the primary growth drivers is the global rise in chronic kidney disease and end-stage renal disease, largely due to aging populations, lifestyle changes, and higher rates of diabetes and hypertension. As more patients require long-term management and renal replacement therapy, the demand for dialysis machines, catheters, and other related devices has increased, supporting market expansion.

The growing preference for minimally invasive surgical techniques has also fueled demand for advanced urology devices. Patients and healthcare providers are increasingly opting for treatments that offer quicker recovery, reduced pain, and fewer complications. Minimally invasive technologies, such as laser lithotripsy for kidney stones and robotic-assisted surgery for prostate and kidney tumors, have become popular choices, driving demand for ureteroscopes, lasers, and robotic systems. This shift toward less invasive interventions has supported the adoption of innovative devices that offer better precision, safety, and effectiveness in treating kidney and urological disorders.

Advancements in medical technology, including digital health tools and portable devices, have contributed to market growth by improving access to care and patient outcomes. Innovations like wearable sensors, remote monitoring devices, and mobile health applications allow for continuous monitoring of patients with chronic conditions, supporting better disease management and timely interventions. For instance, home-based dialysis machines enable more patients to receive treatment outside traditional clinical settings, enhancing convenience and reducing healthcare costs. These advancements align with broader healthcare trends toward personalized, patient-centric care and integrated digital solutions.

Government initiatives and healthcare infrastructure development have also played a key role in driving the nephrology and urology devices market. Increased healthcare spending, improved insurance coverage, and public awareness campaigns about kidney and urological health have boosted the adoption of medical devices in both developed and developing regions. Regulatory support for new device approvals and reimbursement policies has further facilitated access to advanced treatment options, ensuring broader availability of nephrology and urology devices in global markets.

With ongoing innovations in medical devices, telehealth, and minimally invasive techniques, the nephrology and urology devices market is poised for continued growth. These trends, combined with increasing demand for effective disease management, improved patient outcomes, and advanced treatment options, make nephrology and urology devices vital components of modern healthcare strategies across diverse patient populations.

SCOPE OF STUDY:

The report analyzes the Nephrology And Urology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Dialysis Devices, Endoscopy Devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices, Other Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Asahi Kasei Corp
  • B. Braun Group
  • Boston Scientific Corporation
  • Siemens Healthineers
  • Cardinal Health Inc.
  • Cook Group Incorporated
  • Dornier Medtech
  • Medtronic plc
  • Olympus Europa SE & Co. KG
  • Teleflex Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Nephrology And Urology Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Kidney Disorders Drives Demand for Nephrology Devices
    • Expanding Geriatric Population Sets the Stage for Urology Device Adoption
    • Growing Focus on Minimally Invasive Surgeries Propels Device Demand
    • Advancements in Dialysis Technology Strengthen Business Case for Nephrology Devices
    • Increasing Use of Catheters in Urology Drives Market Growth
    • Use in Robotic-assisted Urological Surgeries Expands Addressable Market
    • Growing Applications in Prostate Treatment Enhance Demand for Devices
    • Rising Focus on Home-based Dialysis Sets the Stage for Nephrology Device Growth
    • Increasing Demand for Incontinence Management Drives Urology Device Market
    • Advancements in Stents Propel Demand for Nephrology and Urology Devices
    • Strategic Focus on Telehealth Solutions Generates Opportunities
    • Increasing Use of Nephrostomy Devices Generates Demand
    • Strong Growth in Ambulatory Surgical Centers Drives Nephrology Device Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nephrology And Urology Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nephrology And Urology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dialysis Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dialysis Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Dialysis Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Endoscopy devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Endoscopy devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Endoscopy devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Urinary Stone Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Urinary Stone Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Urinary Stone Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • CHINA
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: China 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Nephrology And Urology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Europe 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 41: France Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: France Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: France 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Germany 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 47: Italy Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Italy Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Italy 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: UK Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: UK 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 53: Spain Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Spain Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Spain 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 56: Russia Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Russia Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Russia 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 59: Rest of Europe Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Rest of Europe Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Rest of Europe 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Nephrology And Urology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 65: Asia-Pacific Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Asia-Pacific Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Asia-Pacific 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 68: Australia Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Australia Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Australia 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • INDIA
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 71: India Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: India Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: India 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 74: South Korea Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: South Korea Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: South Korea 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 77: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Rest of Asia-Pacific Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Rest of Asia-Pacific 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Nephrology And Urology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 83: Latin America Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Latin America Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Latin America 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 86: Argentina Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Argentina Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Argentina 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 89: Brazil Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Brazil Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Brazil 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 92: Mexico Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Mexico Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Mexico 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 95: Rest of Latin America Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Latin America Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Latin America 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Nephrology And Urology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 101: Middle East Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Middle East Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Middle East 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 104: Iran Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Iran Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Iran 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 107: Israel Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Israel Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Israel 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 110: Saudi Arabia Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Saudi Arabia Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Saudi Arabia 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 113: UAE Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UAE Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UAE 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 116: Rest of Middle East Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Middle East Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Middle East 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 119: Africa Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Africa Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Africa 15-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2015, 2025 & 2030

IV. COMPETITION